| 产品详情 |
| Edit |   |
|---|
| Product Name | KRT18, Recombinant, Human, Western Blot Control |
|---|
| Description | Purified (SDS-PAGE). Tissue polypeptide specific antigen was first identified as a tumor marker in the late 1950's, but has recently been shown to be closely related to human cytokeratin 18. Cytokeratins are a group of about 20 cytoskeletal proteins, whose degradation gives rise to soluble fragments, measurable in the blood of patients. Serum levels are high in breast cancer patients and also some other malignancies, probably due to high cell turnover in tumors. Source: Recombinant corresponding to human CK-18, fused to 6x His-tag at N-terminal, expressed in E. coli. Molecular Weight: ~51.6kD Applications: Suitable for use in Western Blot as a control. |
|---|
| Size | 10ug |
|---|
| Concentration | n/a |
|---|
| Applications | WB |
|---|
| Other Names | KRT18, Recombinant, Human, Western Blot Control (Keratin, Type I Cytoskeletal 18, Cytokeratin-18, CK-18, Keratin-18, K18, Cell Proliferation-inducing Gene 46 Protein, PIG46, CYK18) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | K0199-22P |
|---|
| Price | |
|---|
| Order / More Info | KRT18, Recombinant, Human, Western Blot Control from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|